Cibc World Markets Corp Organon & Co. Transaction History

Cibc World Markets Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$16.59 - $23.77 $261,839 - $375,161	-15,783 Reduced 52.81%	14,106 $244,000
Q2 2023 Aug 04, 2023	BUY	$19.27 - $24.63 $328,091 - $419,350	17,026 Added 132.36%	29,889 $621,000
Q1 2023 May 11, 2023	SELL	$21.42 - $32.08 $365,039 - $546,707	-17,042 Reduced 56.99%	12,863 $302,000
Q4 2022 Feb 09, 2023	BUY	$23.31 - $28.61 $697,085 - $855,582	29,905 New	29,905 $835,000
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $1.09 Million - $1.34 Million	-34,450 Reduced 66.05%	17,706 $598,000
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $132,092 - $170,743	4,338 Added 9.07%	52,156 $1.82 Million
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $269,067 - $348,465	-9,385 Reduced 16.41%	47,818 $1.46 Million
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $1.13 Million - $1.41 Million	39,634 Added 225.59%	57,203 $1.88 Million
Q2 2021 Aug 10, 2021	BUY	$28.45 - $38.0 $499,838 - $667,622	17,569 New	17,569 $532,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

Stay updated on Cibc World Markets Corp with notifications on news.